112 related articles for article (PubMed ID: 1968287)
1. Inhibition of gastric acid secretion by jejunal glucose and its relation to osmolality and glucose load.
Holst Pedersen J; Christiansen J; Holst JJ; Krarup T; Hint K; Palmgren N
Scand J Gastroenterol; 1990 Feb; 25(2):103-11. PubMed ID: 1968287
[TBL] [Abstract][Full Text] [Related]
2. A glucose-dependent mechanism in jejunum inhibits gastric acid secretion: a response mediated through enteroglucagon?
Petersen B; Christiansen J; Holst JJ
Scand J Gastroenterol; 1985 Mar; 20(2):193-7. PubMed ID: 3992176
[TBL] [Abstract][Full Text] [Related]
3. The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in man.
Holst JJ; Christiansen J; Kühl C
Scand J Gastroenterol; 1976; 11(3):297-304. PubMed ID: 1273505
[TBL] [Abstract][Full Text] [Related]
4. Jejunal inhibition of pentagastrin-induced gastric acid secretion in man and Heidenhain pouch dogs.
Christiansen J; Holst JJ; Rokkjaer M
Scand J Gastroenterol; 1976; 11(2):219-24. PubMed ID: 1265443
[TBL] [Abstract][Full Text] [Related]
5. Colonic inhibition of gastric secretion in man.
Jian R; Besterman HS; Sarson DL; Aymes C; Hostein J; Bloom SR; Rambaud JC
Dig Dis Sci; 1981 Mar; 26(3):195-201. PubMed ID: 6786845
[TBL] [Abstract][Full Text] [Related]
6. Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man.
Christiansen J; Bech A; Fahrenkrug J; Holst JJ; Lauritsen K; Moody AJ; Schaffalitzky de Muckadell O
Scand J Gastroenterol; 1979; 14(2):161-6. PubMed ID: 107575
[TBL] [Abstract][Full Text] [Related]
7. Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin.
Hammer RA; Fernandez C; Ertan A; Arimura A
Life Sci; 1991; 48(4):333-9. PubMed ID: 1671292
[TBL] [Abstract][Full Text] [Related]
8. Duodenal acidification and jejunal hyperosmolality inhibit pentagastrin-stimulated acid secretion in chronic gastric fistula rats.
Wallin C; Emås S
Scand J Gastroenterol; 1989 Nov; 24(9):1095-101. PubMed ID: 2595271
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous and intrajejunal fat infusion on gastric acid secretion and plasma neurotensin-like immunoreactivity in man.
Petersen B; Christiansen J; Rökaeus A; Rosell S
Scand J Gastroenterol; 1984 Jan; 19(1):48-51. PubMed ID: 6710077
[TBL] [Abstract][Full Text] [Related]
10. Jejunal inhibition of gastric acid secretion induced by hypertonic glucose in duodenal ulcer patients before and after truncal vagotomy.
Christiansen J; Aagaard P; Hansen T
Ann Surg; 1978 Feb; 187(2):122-5. PubMed ID: 629614
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats.
Hammer RA; Ochoa A; Fernandez C; Ertan A; Arimura A
Peptides; 1992; 13(6):1175-9. PubMed ID: 1362980
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pentagastrin-stimulated gastric acid secretion by intraileal administration of bile and elevation of plasma concentrations of gut glucagon-like immunoreactivity in anesthetized dogs.
Namba M; Matsuyama T; Itoh H; Imai Y; Horie H; Tarui S
Regul Pept; 1986 Sep; 15(2):121-8. PubMed ID: 3786834
[TBL] [Abstract][Full Text] [Related]
13. Fat inhibition of gastric acid secretion in man and plasma concentrations of neurotensin-like immunoreactivity.
Kihl B; Rökaeus A; Rosell S; Olbe L
Scand J Gastroenterol; 1981; 16(4):513-26. PubMed ID: 7323689
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
[TBL] [Abstract][Full Text] [Related]
15. Release of somatostatin, neurotensin and vasoactive intestinal peptide upon inhibition of gastric acid secretion by duodenal acid and hyperosmolal solutions in the conscious rat.
Wallin C; Grupcev G; Emås S; Theodorsson E; Hellström PM
Acta Physiol Scand; 1995 Jun; 154(2):193-203. PubMed ID: 7572215
[TBL] [Abstract][Full Text] [Related]
16. Intestinal phase of gastric acid secretion in humans with and without portacaval shunt.
Lenz HJ; Hogan DL; Isenberg JI
Gastroenterology; 1985 Oct; 89(4):791-6. PubMed ID: 3928422
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of neurotensin on gastric acid secretion in rats. Development of a bioassay model.
Hammer RA; Hernandez RE; Shepard A
Dig Dis Sci; 1990 Apr; 35(4):439-43. PubMed ID: 2318089
[TBL] [Abstract][Full Text] [Related]
18. Effects of enteral infusion of hypertonic saline and nutrients on canine jejunal motor patterns.
Schmid HR; Ehrlein HJ
Dig Dis Sci; 1993 Jun; 38(6):1062-72. PubMed ID: 8508701
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man.
O'Halloran DJ; Nikou GC; Kreymann B; Ghatei MA; Bloom SR
J Endocrinol; 1990 Jul; 126(1):169-73. PubMed ID: 2380653
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose exogenous secretin and somatostatin on pentagastrin-stimulated gastric acid secretion in man.
Olsen J; Mortensen PE; Schaffalitzky de Muckadell OB; Holst JJ; Christiansen J
Scand J Gastroenterol; 1989 May; 24(4):493-6. PubMed ID: 2571184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
